List view / Grid view
7 October 2015 | By SMi Group
Leading organizations in the Biosimilars Development sector will meet at Biosimilars and Biobetters USA 2015 – the must-attend premier industry event which will take place in Iselin this November...
7 October 2015 | By Victoria White
Horizon Discovery Group has in-licensed novel kinase inhibitors from Servier that exhibit great promise based on preclinical data for treatment of a range of cancer types...
6 October 2015 | By Victoria White
Cardiff University immunologists have described how an immune system protein - interleukin-27 - regulates the inflammatory process in lymphoid-rich rheumatoid arthritis...
6 October 2015 | By Victoria White
The new building is designed to support the Company’s continuing growth of its research and development operation and is scheduled for delivery in late 2016...
6 October 2015 | By Victoria White
Frost & Sullivan have found that non-therapeutic use of human albumin as an excipient has generated plenty of interest across the industry...
6 October 2015 | By Victoria White
Researchers have found that they can use gene therapy to improve visual in mice models for the vision disorder Leber hereditary optic neuropathy (LHON)...
5 October 2015 | By Victoria White
Initial studies by Oxford University researchers show that targeting the protein, called PAT4, could restrict cancerous cells' ability to grow...
5 October 2015 | By Victoria White
Rats given RGFP966 were more attuned to what they were hearing and were able to retain and remember more information...
5 October 2015 | By Victoria White
The Nobel Prize for Physiology or Medicine has been split this year to recognise work that has revolutionised the treatment of some parasitic diseases...
5 October 2015 | By Victoria White
Biogen will leverage findings from Genomics’ integrated database and analysis tools, which will be used to guide drug research and development...
2 October 2015 | By Victoria White
Elevated levels of TGFb may drive the progression of advanced metastatic cancer. As such, it has become an attractive target for cancer drug development...
2 October 2015 | By Victoria White
The technique allows drugs to last longer in the body and attack both primary cancer tumours and the circulating tumour cells...
2 October 2015 | By Victoria White
Genesphere's goal is to license the 3DNA platform to pharmaceutical partners and complete the preclinical work necessary to advance the its own lead drug candidates...
2 October 2015 | By Victoria White
Scientists have discovered a protein that 'soaks up' the overproduced hormone that leads to diabetic enteropathy...
2 October 2015 | By Victoria White
Understanding how genomic variants contribute to disease may help clinicians develop improved diagnostics and treatments, in addition to new methods of prevention...
